Profiling lung adenocarcinoma by liquid biopsy: can one size fit all?

BACKGROUND: Cancer is first and foremost a disease of the genome. Specific genetic signatures within a tumour are prognostic of disease outcome, reflect subclonal architecture and intratumour heterogeneity, inform treatment choices and predict the emergence of resistance to targeted therapies. Minim...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Nanotechnol
Prif Awduron: Clifford, Harry W., Cassidy, Amy P., Vaughn, Courtney, Tsai, Evaline S., Seres, Bianka, Patel, Nirmesh, O’Neill, Hannah L., Hewage, Emil, Cassidy, John W.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Vienna 2016
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119837/
https://ncbi.nlm.nih.gov/pubmed/27933110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12645-016-0023-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg